Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

Study confirms “MSM provides moderate evidence of efficacy for knee OA”
2007-04-06 -




Arthritis Research & Therapy reviews 2,026 OA nutritional supplement studies and concludes that only three supplements including MSM are supported by good to moderate evidence.

VANCOUVER, Wash. USA, April 4, 2007—Researchers from the Nestle Research Center, Lausanne, Switzerland, Laurent G. Ameye and Winnie S.S. Chee, have concluded that of 2,026 human clinical trials evaluating the effects of nutritional compounds on osteoarthritis, only 53 studies provided minimum acceptable evidence and only three nutrients, including methylsulfonylmethane or MSM, showed good to moderate evidence.  The research was published in Arthritis Research & Therapy, July 2006. The study did not include evidence for glucosamine or chondroitin sulfates, which are known to have significant research support. 

Good evidence was found for avocado soybean unsaponifiables. Moderate evidence was found for methylsulfonylmethane and SKI306X, a cocktail of plant extracts. In regards to MSM, the research noted two randomized clinical trials, qualified to be evaluated in this systematic review. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonyl-methane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial, Osteoarthritis and Cartilage 2006;14:286–94;  Usha PR, Naidu MUR. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Invest 2004; 24:353–63. According to the best-evidence synthesis, “MSM provides moderate evidence of efficacy for knee OA.”

The researchers concluded that “overall, scientific evidence exists for some specific nutritional interventions to provide symptom relief to osteoarthritic patients. It remains to be investigated whether nutritional compounds can have structure-modifying effects.” The full article is online at http://arthritis-research.com/content/8/4/R127.

A bibliography of MSM research is available at http://www.msmguide.com/msm-practitioner/msm-research-papers.html.

#   #  #

Contact: Leo MacLeod
503-880-8393
leo@mainspringmarketing.com

 

Advertisement



Sponsored Links: Featured Links:
 

NPIcenter Address and Phone Number
Contact Us | Privacy Policy | Terms of Use | Advertise
New Hope Natural Media

 

SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon